Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug Administration in July.

Commonly used fecal immunochemical tests vary in their performance, which has implications for the benefits and ...

A snowman picking his nose made people who typically avoid informataion about colorectal cancer more likely to take a quiz ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

Exact Sciences released data from a study of its blood-based colorectal cancer screening test that showed sensitivities of 88.3% for colorectal cancer and 31.2% for advanced precancerous lesions.

Colon cancer is increasingly affecting the younger population. It's essential to be informed about the risk factors and ...